AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance

Go back to AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance

AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance

March 30, 2021 7:03 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $71.2 million versus the consensus estimate of $68.95 million.

GUIDANCE:

AngioDynamics sees FY2021 EPS of $0.04-$0.06, versus the consensus of $0.01. AngioDynamics sees... More